1. Home
  2. SLNO vs RYN Comparison

SLNO vs RYN Comparison

Compare SLNO & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • RYN
  • Stock Information
  • Founded
  • SLNO 1999
  • RYN 1926
  • Country
  • SLNO United States
  • RYN United States
  • Employees
  • SLNO N/A
  • RYN N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RYN Real Estate Investment Trusts
  • Sector
  • SLNO Health Care
  • RYN Real Estate
  • Exchange
  • SLNO Nasdaq
  • RYN Nasdaq
  • Market Cap
  • SLNO 3.8B
  • RYN 3.7B
  • IPO Year
  • SLNO 2014
  • RYN N/A
  • Fundamental
  • Price
  • SLNO $65.46
  • RYN $24.94
  • Analyst Decision
  • SLNO Strong Buy
  • RYN Hold
  • Analyst Count
  • SLNO 9
  • RYN 4
  • Target Price
  • SLNO $116.78
  • RYN $28.00
  • AVG Volume (30 Days)
  • SLNO 1.7M
  • RYN 1.1M
  • Earning Date
  • SLNO 11-05-2025
  • RYN 11-05-2025
  • Dividend Yield
  • SLNO N/A
  • RYN 11.60%
  • EPS Growth
  • SLNO N/A
  • RYN 389.17
  • EPS
  • SLNO N/A
  • RYN 4.92
  • Revenue
  • SLNO $32,656,999.00
  • RYN $1,239,943,000.00
  • Revenue This Year
  • SLNO N/A
  • RYN N/A
  • Revenue Next Year
  • SLNO $182.29
  • RYN $2.18
  • P/E Ratio
  • SLNO N/A
  • RYN $10.30
  • Revenue Growth
  • SLNO N/A
  • RYN 40.53
  • 52 Week Low
  • SLNO $41.50
  • RYN $21.84
  • 52 Week High
  • SLNO $90.32
  • RYN $32.88
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 51.66
  • RYN 41.63
  • Support Level
  • SLNO $63.02
  • RYN $24.09
  • Resistance Level
  • SLNO $72.88
  • RYN $25.29
  • Average True Range (ATR)
  • SLNO 4.25
  • RYN 0.66
  • MACD
  • SLNO 1.03
  • RYN -0.23
  • Stochastic Oscillator
  • SLNO 56.61
  • RYN 28.45

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About RYN Rayonier Inc. REIT

Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.

Share on Social Networks: